<?xml version="1.0" encoding="UTF-8"?>
<p class="p">In pathological conditions and, for example, in the case of excessive exposure of the skin to UV radiation, the redox balance is disturbed and oxidative stress occurs, which results in the activation of cytosolic phospholipase A2 (cPLA
 <sub class="sub">2</sub>) and PLC in the skin cells [
 <xref rid="B18-antioxidants-07-00108" ref-type="bibr" class="xref">18</xref>]. This leads to the excessive release of AA and the increased production of eicosanoids via cyclooxygenases and lipoxygenases. COX-1 and COX-2 catalyze the transformation of arachidonic acid into the series 2 prostanoids (PGE
 <sub class="sub">2</sub>, PGD
 <sub class="sub">2</sub>, PGI
 <sub class="sub">2</sub>, TXA
 <sub class="sub">2</sub>, and TXB
 <sub class="sub">2</sub>). Moreover, 5-lipoxygenase (5-LOX) metabolizes arachidonic acid to series 4 leukotrienes (LTB
 <sub class="sub">4</sub>, LTC
 <sub class="sub">4</sub>, LTD
 <sub class="sub">4</sub>, and LTE
 <sub class="sub">4</sub>) [
 <xref rid="B18-antioxidants-07-00108" ref-type="bibr" class="xref">18</xref>,
 <xref rid="B31-antioxidants-07-00108" ref-type="bibr" class="xref">31</xref>]. Prostaglandins, series 2 thromboxanes, and series 4 leukotrienes belong to the pro-inflammatory eicosanoids [
 <xref rid="B31-antioxidants-07-00108" ref-type="bibr" class="xref">31</xref>]. However, 15-lipoxygenase (15-LOX) catalyzes the conversion of arachidonic acid to 15-hydroxyeicosatetraenoic acid (15-HETE), whose metabolites are lipoxins. These compounds have anti-inflammatory properties [
 <xref rid="B18-antioxidants-07-00108" ref-type="bibr" class="xref">18</xref>,
 <xref rid="B31-antioxidants-07-00108" ref-type="bibr" class="xref">31</xref>]. Moreover, 15-HETE can inhibit the formation of 12-HETE, which is a metabolite of 12-LOXâ€™s catalytic action on arachidonic acid [
 <xref rid="B18-antioxidants-07-00108" ref-type="bibr" class="xref">18</xref>].
</p>
